HK1007110A1 - Method and compositions for treating alzheimer's disease related dementias & epilepsy - Google Patents

Method and compositions for treating alzheimer's disease related dementias & epilepsy

Info

Publication number
HK1007110A1
HK1007110A1 HK98106406A HK98106406A HK1007110A1 HK 1007110 A1 HK1007110 A1 HK 1007110A1 HK 98106406 A HK98106406 A HK 98106406A HK 98106406 A HK98106406 A HK 98106406A HK 1007110 A1 HK1007110 A1 HK 1007110A1
Authority
HK
Hong Kong
Prior art keywords
epilepsy
derivatives
compositions
related dementias
disease related
Prior art date
Application number
HK98106406A
Other languages
English (en)
Inventor
Shlomo Yehuda
Original Assignee
Univ Bar Ilan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/376,289 external-priority patent/US5120763A/en
Priority claimed from IL9180289A external-priority patent/IL91802A/en
Application filed by Univ Bar Ilan filed Critical Univ Bar Ilan
Publication of HK1007110A1 publication Critical patent/HK1007110A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98106406A 1988-10-27 1998-06-24 Method and compositions for treating alzheimer's disease related dementias & epilepsy HK1007110A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26354088A 1988-10-27 1988-10-27
US35956289A 1989-06-01 1989-06-01
US07/376,289 US5120763A (en) 1986-11-26 1989-07-06 Physiologically active and nutritional composition
IL9180289A IL91802A (en) 1988-10-27 1989-09-27 Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy

Publications (1)

Publication Number Publication Date
HK1007110A1 true HK1007110A1 (en) 1999-04-01

Family

ID=27452355

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106406A HK1007110A1 (en) 1988-10-27 1998-06-24 Method and compositions for treating alzheimer's disease related dementias & epilepsy

Country Status (6)

Country Link
EP (1) EP0366480B1 (ja)
JP (1) JP2810725B2 (ja)
AT (1) ATE110268T1 (ja)
AU (1) AU620929B2 (ja)
DE (1) DE68917678T2 (ja)
HK (1) HK1007110A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651975B2 (en) * 1990-05-22 1994-08-11 Harold Bumann Foodstuff with prophylactic and/or curative effect and process for making it
US6103755A (en) * 1990-05-22 2000-08-15 Bumann; Harold Foodstuff with prophylactic and/or healing effect and process for its production
DE4116004C2 (de) * 1991-05-16 1993-09-30 Fresenius Ag Nährstoffzubereitung
GB9423625D0 (en) * 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
DE19549262C2 (de) * 1995-02-08 1997-10-09 Martin Dr Kohlmeier Präparat zur Abschätzung des Entstehungsrisikos eines beschleunigten Verlustes kognitiver Fähigkeiten
ATE185949T1 (de) 1995-07-28 1999-11-15 Herbert Schlachter Zwei-phasen-präparat
AU735687B2 (en) * 1997-07-28 2001-07-12 Riken Agent for protecting central nerve cells and enhancing survival thereof
DE102005037298A1 (de) * 2005-08-08 2007-03-08 Christine Jaschek Verwendung von Kalium-, Magnesium-, Calcium- und Zink-Elektrolyten zur Behandlung des Elementemangel- und Austrocknungssyndroms Alzheimer und anderer Demenzen
EP1772146A1 (en) * 2005-10-03 2007-04-11 Neuropharma, S.A. Polyunsaturated fatty acids as bace inhibitors
US10052299B2 (en) 2009-10-30 2018-08-21 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
WO2012148926A2 (en) * 2011-04-26 2012-11-01 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating pufas
EP3730135A1 (en) 2011-04-26 2020-10-28 Retrotope, Inc. Impaired energy processing disorders and mitochondrial deficiency
EP3689342A1 (en) 2011-04-26 2020-08-05 Retrotope, Inc. Oxidative retinal diseases
US10154978B2 (en) 2011-04-26 2018-12-18 Retrotope, Inc. Disorders implicating PUFA oxidation
KR101493139B1 (ko) * 2013-01-08 2015-02-13 경상대학교산학협력단 타이모퀴논 및 비타민 c를 유효성분으로 포함하는 신경세포 보호용 조성물
JP2016023163A (ja) * 2014-07-22 2016-02-08 出光興産株式会社 γ−リノレン酸を含む神経細胞の酸化ストレス軽減剤
US10730821B2 (en) 2015-11-23 2020-08-04 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
JP2023514711A (ja) 2020-02-21 2023-04-07 レトロトップ、 インコーポレイテッド 多価不飽和脂肪酸及びその誘導体の同位体修飾方法
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition

Also Published As

Publication number Publication date
AU4380589A (en) 1990-05-03
DE68917678T2 (de) 1994-12-22
JP2810725B2 (ja) 1998-10-15
AU620929B2 (en) 1992-02-27
EP0366480A2 (en) 1990-05-02
EP0366480B1 (en) 1994-08-24
JPH02237919A (ja) 1990-09-20
EP0366480A3 (en) 1991-02-06
ATE110268T1 (de) 1994-09-15
DE68917678D1 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
HK1007110A1 (en) Method and compositions for treating alzheimer's disease related dementias & epilepsy
ATE198833T1 (de) Cyclosporin enthaltende flüssige zubereitungen und verfahren zu ihrer herstellung
GR3003120T3 (en) Pharmaceutical compositions
IL108147A0 (en) Compositions of l-dopa esters
MY110734A (en) Improvements in or relating to dioic acids.
IL94819A0 (en) 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PT79648A (de) Verfahren zur herstellung von pharmazeutischen zubereitungen mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darm-bereich
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
EP0376899B1 (en) Use of l-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies
DE60002126D1 (de) Substituierte dimere Carboxamid-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
EP0305400A4 (en) LOW NEPHROTOXICITY COMPOSITION COMPRISING A FATTY ACID AND CYCLOCPORIN CONTAINING COMPONENT.
EP0652755A1 (en) THERAPEUTIC USE OF PHOSPHORYL-L-SERINE-N-ACYL-SPHINGOSINE.
IL94693A0 (en) Dibenzo(1,5)dioxocin-5-one derivatives,their preparation and pharmaceutical compositions containing them
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
CS368890A3 (en) Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them
HU913009D0 (en) Method for producing inhibitors of calcium ingestion
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
DE69619266D1 (de) Arzneizubereitungen enthaltend arctium majus

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20071027